BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Treatment
7 results:

  • 1. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the treatment of pancreatic Adenocarcinoma.
    Di Giorgio C; Lupia A; Marchianò S; Bordoni M; Bellini R; Massa C; Urbani G; Roselli R; Moraca F; Sepe V; Catalanotti B; Morretta E; Monti MC; Biagioli M; Distrutti E; Zampella A; Fiorucci S
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359879
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
    Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
    Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.
    Hunter SA; McIntosh BJ; Shi Y; Sperberg RAP; Funatogawa C; Labanieh L; Soon E; Wastyk HC; Mehta N; Carter C; Hunter T; Cochran JR
    Commun Biol; 2021 Apr; 4(1):452. PubMed ID: 33846527
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy.
    Fujikura K; Hutchings D; Braxton AM; Zhu Q; Laheru DA; Hruban RH; Thompson ED; Wood LD
    Mod Pathol; 2020 Oct; 33(10):2026-2034. PubMed ID: 32457408
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma.
    Ma JH; Patrut E; Schmidt J; Knaebel HP; Büchler MW; Märten A
    World J Gastroenterol; 2005 Mar; 11(10):1521-8. PubMed ID: 15770730
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
    Feliu J; Mel R; Borrega P; López Gómez L; Escudero P; Dorta J; Castro J; Vázquez-Estévez SE; Bolaños M; Espinosa E; González Barón M;
    Ann Oncol; 2002 Nov; 13(11):1756-62. PubMed ID: 12419748
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.